Carl Zeiss Meditec AG (CZMWY)
OTCMKTS
· Delayed Price · Currency is USD
51.72
+0.58 (1.13%)
Jan 22, 2025, 10:14 AM EST
Carl Zeiss Meditec AG Revenue
In the fiscal year ending September 30, 2024, Carl Zeiss Meditec AG had annual revenue of 2.07B EUR, down -1.11%. Carl Zeiss Meditec AG had revenue of 579.63M in the quarter ending September 30, 2024, a decrease of -0.01%.
Revenue
2.07B EUR
Revenue Growth
-1.11%
P/S Ratio
n/a
Revenue / Employee
360.58K EUR
Employees
5,730
Market Cap
4.51B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 2.07B | -23.17M | -1.11% |
Sep 30, 2023 | 2.09B | 186.46M | 9.80% |
Sep 30, 2022 | 1.90B | 256.05M | 15.55% |
Sep 30, 2021 | 1.65B | 311.33M | 23.31% |
Sep 30, 2020 | 1.34B | -123.87M | -8.49% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
Veradigm | 1.53B |
SS Innovations International | 16.04M |
Elite Pharmaceuticals | 71.17M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
BioStem Technologies | 210.49M |
Silence Therapeutics | 21.77M |
Carl Zeiss Meditec AG News
- 7 weeks ago - Carl Zeiss: Why I Am So Positive - Seeking Alpha
- 4 months ago - My 3 Favorite European Stocks To Diversify Your Portfolio - Seeking Alpha
- 4 months ago - Carl Zeiss: Significant Underperformance, Valuation At Multi-Year Lows - Seeking Alpha
- 5 months ago - Carl Zeiss Meditec AG (CZMWF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 months ago - Carl Zeiss Meditec: Slightly Better Valuation, Still A Significant Upside - Seeking Alpha
- 9 months ago - Carl Zeiss Meditec AG (CZMWF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 10 months ago - Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market - PRNewsWire
- 1 year ago - Carl Zeiss: We've Seen Outperformance, But I See More Upside Potential - Seeking Alpha